Ergang Shi

1.9k total citations · 1 hit paper
14 papers, 1.4k citations indexed

About

Ergang Shi is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Ergang Shi has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cell Biology and 5 papers in Cancer Research. Recurrent topics in Ergang Shi's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Ergang Shi is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Ergang Shi collaborates with scholars based in United States. Ergang Shi's co-authors include Ashique Rafique, Joel Martin, Neil Stahl, Stanley J. Wiegand, Erica Pyles, Qin Ruan, Nicholas Papadopoulos, George D. Yancopoulos, Michael Rosconi and Wallace L. McKeehan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Molecular and Cellular Biology.

In The Last Decade

Ergang Shi

14 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

2012 823 citations Nicholas Papadopoulos, Joel Martin et al. Angiogenesis profile →

Peers

Countries citing papers authored by Ergang Shi

Since Specialization

Citations

This map shows the geographic impact of Ergang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ergang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ergang Shi more than expected).

Fields of papers citing papers by Ergang Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ergang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ergang Shi. The network helps show where Ergang Shi may publish in the future.

Co-authorship network of co-authors of Ergang Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ergang Shi. A scholar is included among the top collaborators of Ergang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ergang Shi. Ergang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models 2014 ·Molecular Cancer Therapeutics ·Li Zhang, Carla Castanaro, (unknown), (unknown), (unknown), Jeanette Fairhurst, Ashique Rafique, Terra Potocky, Jing Shan, Frank J. Delfino, Ergang Shi, Tammy Huang, Joel Martin, Gang Chen, Douglas MacDonald, John S. Rudge, Gavin Thurston, Christopher Daly	42
2	Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab breakdown → 2012 ·Angiogenesis ·Nicholas Papadopoulos, Joel Martin, Qin Ruan, Ashique Rafique, Michael Rosconi, Ergang Shi, Erica Pyles, George D. Yancopoulos, Neil Stahl, Stanley J. Wiegand	823
3	Monoclonal antibody classification based on epitope-binding using differential antigen disruption 2006 ·Journal of Immunological Methods ·Ergang Shi, Wen Fury, Wentian Li, (unknown), Thomas H. Aldrich, Ashique Rafique, Gang Chen, Simon Hoffenberg, Thomas J. Daly, Czeslaw Radziejewski	9
4	Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein. 2000 ·PubMed ·Xiaochuan Xu, (unknown), (unknown), John E. Shively, Lawrence E. Williams, Yu Shyr, Ergang Shi, F. James Primus	70
5	Phosphospecific antibodies reveal focal adhesion kinase activation loop phosphorylation in nascent and mature focal adhesions and requirement for the autophosphorylation site. 2000 ·PubMed ·(unknown), (unknown), Ergang Shi, Raymond L. Mernaugh, Steven K. Hanks	81
6	Functional genomics in mice by tagged sequence mutagenesis 1997 ·Nature Genetics ·Geoffrey G. Hicks, Ergang Shi, (unknown), Chunhua Li, Maciej Pawlak, H. Earl Ruley	97
7	[17] Retrovirus gene traps 1995 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Geoffrey G. Hicks, Ergang Shi, Jin Chen, Michael Roshon, (unknown), Constanze R Scherer, H. Earl Ruley	9
8	Inositolhexakisphosphate (InsP6): An antagonist of fibroblast growth factor receptor binding and activity 1994 ·In Vitro Cellular & Developmental Biology - Animal ·Richard S. Morrison, Ergang Shi, Mikio Kan, Fumio Yamaguchi, Wallace L. McKeehan, (unknown), Krzysztof Palczewski	25
9	Control of Fibroblast Growth Factor Receptor Kinase Signal Transduction by Heterodimerization of Combinatorial Splice Variants 1993 ·Molecular and Cellular Biology ·Ergang Shi, Mikio Kan, Jianming Xu, Fen Wang, Jinzhao Hou, Wallace L. McKeehan	108
10	Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms. 1992 ·Journal of Biological Chemistry ·Jianming Xu, M. Nakahara, John W. Crabb, Ergang Shi, Yuhsi Matuo, Murray Fraser, M Kan, Jinzhao Hou, Wallace L. McKeehan	77
11	Identification and assay of fibroblast growth factor receptors 1991 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Mikio Kan, Ergang Shi, Wallace L. McKeehan	39
12	16-kilodalton heparin binding (fibroblast) growth factor type one appears in a stable 40-kilodalton complex after receptor-dependent internalization. 1991 ·Journal of Biological Chemistry ·Ergang Shi, M Kan, Jia Xu, Wallace L. McKeehan	19
13	Fibronectin, not laminin, mediates heparin-dependent heparin-binding growth factor type I binding to substrata and stimulation of endothelial cell growth 1990 ·In Vitro Cellular & Developmental Biology - Plant ·Mikio Kan, Ergang Shi	15
14	Purification from human hepatoma cells of a 130-kDa membrane glycoprotein with properties of the heparin-binding growth factor receptor 1988 ·Biochemical and Biophysical Research Communications ·Dennis M. DiSorbo, Ergang Shi, (unknown)	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact